The Food and Drug Administration has announced a public workshop entitled, “Scientific Evidence in the Development of Human Cells, Tissues, and Cellular and Tissue-Based Products Subject to Premarket Approval.” [Read more…]
CDI and National Eye Institute to Collaborate on iPSC-Derived Cell Therapies for Retinal Degenerative Disease
Headquartered in Madison, Wisconsin, Cellular Dynamics International (CDI) is powerhouse within the induced pluripotent stem cell (iPSC) industry. The company was founded in 2004 and listed on NASDAQ stock exchange in July 2013. Today, the company has more than than 150 employees, as well as an extremely robust patent portfolio of more than 800 stem cell related patents of which approximately 130 pertain to iPSCs.
In major news released this week, CDI announced that it has partnered with the National Eye Institute to develop cell transplantation therapies for retinal degenerative disease. [Read more…]
Understand Stem Cell Market Needs, so You Can Precisely Meet Them – with Minimal Time, Cost, and Risk
As a provider of stem cell products and technologies, you know you need to:
- Make effective product development decisions
- Sell more effectively
- Generate improved revenues
- Take market share
Without strategic guidance on which to base your actions, you’re in a difficult position. New products that don’t sell well are costly mistakes. On the other hand, repeatedly launching high-demand products and skillfully addressing the unmet needs of your clients is certain to position you as a market leader.
[Read more…]
Historic Patent Challenges to Pluripotent Stem Cells (ESCs and iPSCs)
Two of the most versatile and powerful pluripotent stem cell types are embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). For this reason, the patent environment surrounding these stem cell types is complicated, and there are a number of restrictions on how the cells can be used for commercial purposes.
The most infamous stem cell patents are held by the Wisconsin Alumni Research Foundation (WARF) and concern the derivation of human embryonic stem cells (hESCs). Founded in 1925, the Wisconsin Alumni Research Foundation (WARF) is a nonprofit patent and licensing organization for the University of Wisconsin–Madison.” It manages a $2.6 billion endowment build over 90 years of licensing activity , making it one of the world’s most successful university-based technology transfer offices. [Read more…]
ORIG3N and Kangstem Biotech Partner to Investigate Induced Neural Stem Cells for Disease Modeling
Boston biotech company ORIG3N has announced a collaboration with South Korea’s Kangstem Biotech in a joint effort to gain insight on the effectiveness of induced neural stem cells (iNSC) in disease modeling. As a pioneer of regenerative medicine, ORIG3N is leading the way towards the future of medicine by crowdsourcing blood samples to create the world’s largest and most diverse biorepository of stem cells.
As part of this collaboration, Kangstem Biotech will be providing iNSC’s to ORIG3N for research. This partnership between a pioneer in the biotechnology industry and one of the largest global biopharmaceutical companies is an exciting development in regenerative medicine. [Read more…]
- « Previous Page
- 1
- …
- 244
- 245
- 246
- 247
- 248
- …
- 307
- Next Page »